OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vaccines, new opportunities for a new society
Rino Rappuoli, Mariagrazia Pizza, Giuseppe Del Giudice, et al.
Proceedings of the National Academy of Sciences (2014) Vol. 111, Iss. 34, pp. 12288-12293
Open Access | Times Cited: 310

Showing 26-50 of 310 citing articles:

Potential Application of Exosomes in Vaccine Development and Delivery
Md Nurul Huda, Md Nurunnabi
Pharmaceutical Research (2022) Vol. 39, Iss. 11, pp. 2635-2671
Open Access | Times Cited: 52

The Potential Role of Vaccines in Preventing Antimicrobial Resistance (AMR): An Update and Future Perspectives
Vincenzo Costanzo, Giovanni N. Roviello
Vaccines (2023) Vol. 11, Iss. 2, pp. 333-333
Open Access | Times Cited: 37

Antibiotic resistance—A global crisis
Elisabeth Zeuko’o Menkem
Elsevier eBooks (2023), pp. 375-389
Closed Access | Times Cited: 26

Extracellular vesicles associated microRNAs: Their biology and clinical significance as biomarkers in gastrointestinal cancers
Yuan Li, Silei Sui, Ajay Goel
Seminars in Cancer Biology (2024) Vol. 99, pp. 5-23
Closed Access | Times Cited: 12

Leishmania vaccine development: A comprehensive review
Isha Saini, Jyoti Joshi, Sukhbir Kaur
Cellular Immunology (2024) Vol. 399-400, pp. 104826-104826
Closed Access | Times Cited: 8

Cell culture-based influenza vaccines: A necessary and indispensable investment for the future
Nagendra R. Hegde
Human Vaccines & Immunotherapeutics (2015) Vol. 11, Iss. 5, pp. 1223-1234
Open Access | Times Cited: 87

Fighting against a protean enemy: immunosenescence, vaccines, and healthy aging
Giuseppe Del Giudice, Jörg J. Goronzy, Beatrix Grubeck‐Loebenstein, et al.
npj Aging and Mechanisms of Disease (2017) Vol. 4, Iss. 1
Open Access | Times Cited: 86

A Bacteriophage T4 Nanoparticle-Based Dual Vaccine against Anthrax and Plague
Tao Pan, Marthandan Mahalingam, Jingen Zhu, et al.
mBio (2018) Vol. 9, Iss. 5
Open Access | Times Cited: 79

Reverse Vaccinology: An Approach for Identifying Leptospiral Vaccine Candidates
Odir Antônio Dellagostin, André Alex Grassmann, Caroline Rizzi, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 1, pp. 158-158
Open Access | Times Cited: 70

Cell culture-derived flu vaccine: Present and future
Alberto Pérez Rubio, José Marı́a Eiros Bouza
Human Vaccines & Immunotherapeutics (2018) Vol. 14, Iss. 8, pp. 1874-1882
Open Access | Times Cited: 65

Challenges in adult vaccination
Eduardo de Gomensoro, Giuseppe Del Giudice, T. Mark Doherty
Annals of Medicine (2018) Vol. 50, Iss. 3, pp. 181-192
Open Access | Times Cited: 64

EpiDope: a deep neural network for linear B-cell epitope prediction
Maximilian Collatz, Florian Mock, Emanuel Barth, et al.
Bioinformatics (2020) Vol. 37, Iss. 4, pp. 448-455
Open Access | Times Cited: 62

In silico Design of an Epitope-Based Vaccine Ensemble for Chagas Disease
Lucas Michel-Todó, Pedro A. Reche, Pascal Bigey, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 58

Anesthesiologists’ Role in Value-based Perioperative Care and Healthcare Transformation
Aman Mahajan, Stephen A. Esper, Daniel J. Cole, et al.
Anesthesiology (2021) Vol. 134, Iss. 4, pp. 526-540
Open Access | Times Cited: 50

Lipopolysaccharide Detection across the Kingdoms of Life
Jonathan C. Kagan
Trends in Immunology (2017) Vol. 38, Iss. 10, pp. 696-704
Open Access | Times Cited: 60

M cell targeting engineered biomaterials for effective vaccination
Mohammad Ariful Islam, Jannatul Firdous, Abu Zayed Md Badruddoza, et al.
Biomaterials (2018) Vol. 192, pp. 75-94
Closed Access | Times Cited: 52

Enhancing vaccine safety capacity globally: A lifecycle perspective
Robert T. Chen, Tom T. Shimabukuro, David Martin, et al.
Vaccine (2015) Vol. 33, pp. D46-D54
Open Access | Times Cited: 51

Biologics to treat substance use disorders: Current status and new directions
Marco Pravetoni
Human Vaccines & Immunotherapeutics (2016) Vol. 12, Iss. 12, pp. 3005-3019
Open Access | Times Cited: 49

Recent advances in immunotherapies against infectious diseases
Dharanidharan Ramamurthy, Trishana Nundalall, Sanele Cingo, et al.
Immunotherapy Advances (2020) Vol. 1, Iss. 1
Open Access | Times Cited: 49

Current Advances in Sustained Release Microneedles
Guangsheng Du, Xun Sun
Pharmaceutical Fronts (2020) Vol. 02, Iss. 01, pp. e11-e22
Open Access | Times Cited: 47

Polyphosphazene immunoadjuvants: Historical perspective and recent advances
Alexander K. Andrianov, Róbert Langer
Journal of Controlled Release (2020) Vol. 329, pp. 299-315
Open Access | Times Cited: 42

Supply and delivery of vaccines for global health
Jean‐Louis Excler, Lois Privor-Dumm, Jérôme H. Kim
Current Opinion in Immunology (2021) Vol. 71, pp. 13-20
Open Access | Times Cited: 37

Scroll to top